© palliativedrugs.com

palliativedrugs
8q3j7l1ll1unljrvsf8ff5bln6
Array ( ) © palliativedrugs.com

Prelims

Preface
How PCF is constructed
Summary of main changes
Monographs available elsewhere
Getting the most out of PCF
The use of medicinal products beyond (off-label) and without (unauthorized) Marketing Authorization

Part 1 Drug Monographs

(Expand All | Collapse All)

1 Gastro-intestinal system
2 Cardiovascular system
- Furosemide
- Spironolactone
- Systemic local anaesthetics
- *Clonidine
- Glyceryl trinitrate
- Nifedipine
- Anticoagulants
  - Low molecular weight heparin (LMWH)
- Haemostatics
- Quick Clinical Guide
  - Quick Clinical Guide: Heparin-Induced Thrombocytopenia (HIT)
3 Respiratory system
4 Central nervous system
5 Analgesics
6 Infections
7 Endocrine system and immunomodulation
8 Urinary tract disorders
9 Nutrition and blood
10 Musculoskeletal and joint diseases
11 Ear, nose and oropharynx
12 Skin
13 Anaesthesia
- *Ketamine
- *Propofol

Part 2 General Topics

14 Prescribing in palliative care
15 Anticipatory prescribing in the community
16 Prescribing for children
17 Renal impairment
18 Hepatic impairment
19 Variability in response to drugs
20 Prolongation of the QT interval in palliative care
21 Drug-induced movement disorders
22 Drugs and fitness to drive
23 Taking controlled and prescription drugs to other countries
24 Obtaining specials
25 Management of postoperative pain in opioid-dependent patients
26 Drugs for pruritus
27 Oral nutritional supplements
28 Drug administration to patients with swallowing difficulties or enteral feeding tubes
29 Continuous subcutaneous drug infusions
30 Transdermal patches
31 Nebulized drugs
32 Spinal analgesia

Appendices

Quick Clinical Guides